Abstract

Troglitazone decreases insulin resistance and improves glucose tolerance in obese subjects with either impaired or normal glucose tolerance. The ability of troglitazone to reduce insulin resistance could be useful in preventing NIDDM:

Keywords

TroglitazoneMedicineInsulin resistanceInternal medicineEndocrinologyInsulinImpaired glucose toleranceObesity

Affiliated Institutions

Related Publications

Publication Info

Year
1994
Type
article
Volume
331
Issue
18
Pages
1188-1193
Citations
932
Access
Closed

External Links

Social Impact

Social media, news, blog, policy document mentions

Citation Metrics

932
OpenAlex

Cite This

John J. Nolan, Bernhard Ludvik, P. Beerdsen et al. (1994). Improvement in Glucose Tolerance and Insulin Resistance in Obese Subjects Treated with Troglitazone. New England Journal of Medicine , 331 (18) , 1188-1193. https://doi.org/10.1056/nejm199411033311803

Identifiers

DOI
10.1056/nejm199411033311803